When does ImmunoCellular Therapeutics, Ltd. report earnings?
ImmunoCellular Therapeutics, Ltd. reports earnings every quartal, last ImmunoCellular Therapeutics, Ltd. earnings report date was 28/08/2018.
How much is ImmunoCellular Therapeutics, Ltd. earnings per share?
ImmunoCellular Therapeutics, Ltd. estimated earnings per share was -0.01 $ last time.
When is ImmunoCellular Therapeutics, Ltd. next earnings report?
Next ImmunoCellular Therapeutics, Ltd. earnings call will be in August 2024.
ImmunoCellular Therapeutics, Ltd. earnings per share of the company - one of the indicators of the company's income from the size of its value. Earnings per share are calculated according to the formula: the amount of the company's profit for the financial period according to official reports is divided by the number of shares in the company. It is clear that ImmunoCellular Therapeutics, Ltd. earnings per share is a financial characteristic for a certain period. Profit of ImmunoCellular Therapeutics, Ltd. - the entire profit of the company in the reporting period.
Show:
to
ImmunoCellular Therapeutics, Ltd. earnings report
All ImmunoCellular Therapeutics, Ltd. profits are a reference. It is not so important to private shareholders. More important is the calculation of earnings per share. This value is the basis for calculating dividends and is much more in demand by the attention of shareholders. The date of the ImmunoCellular Therapeutics, Ltd. profit report is set by the organization’s management. The dates of ImmunoCellular Therapeutics, Ltd. profit statements for recent periods are shown in the table and graph of our online service.
Earnings per share ImmunoCellular Therapeutics, Ltd. is calculated by dividing the company's profit by the number of its shares. Earnings per share ImmunoCellular Therapeutics, Ltd. is an indicator of a certain financial interval. It is easy to guess that the financial period coincides with the publication of financial statements of profit. ImmunoCellular Therapeutics, Ltd. earnings per share for the last reporting period can be found in our table (the top row) or graph (the rightmost column). Quarterly profit ImmunoCellular Therapeutics, Ltd. is the main type of financial statements among companies.
IMUC earnings date
Estimated EPS
A company's earnings per share, or EPS, is calculated by dividing net income (or profits) to the number of company's shares.
Change for a year %
28/08/2018
-0.01 USD
-
27/08/2018
-0.01 USD
-
26/08/2018
-0.01 USD
-
25/08/2018
-0.01 USD
-
24/08/2018
-0.01 USD
-
23/08/2018
-0.01 USD
-
22/08/2018
-0.01 USD
-
21/08/2018
-0.01 USD
-
20/08/2018
-0.01 USD
-
19/08/2018
-0.01 USD
-
18/08/2018
-0.01 USD
-
17/08/2018
-0.01 USD
-
16/08/2018
-0.01 USD
-
15/08/2018
-0.01 USD
-
14/08/2018
-0.01 USD
-
13/08/2018
-0.01 USD
+99.02% ↑
14/05/2018
-0.02 USD
+98.78% ↑
21/11/2017
-0.4 USD
+75% ↑
14/08/2017
-1.02 USD
+57.5% ↑
ImmunoCellular Therapeutics, Ltd. quarterly earnings per share is also one of the organization’s profitability indicators, although less popular than annual earnings per share. Last quarterly profit ImmunoCellular Therapeutics, Ltd. today is the officially declared profit for the last reference quarter. The change in profit of ImmunoCellular Therapeutics, Ltd. for the year is calculated in comparison with the same financial period as the current indicator only for the previous year. A change in ImmunoCellular Therapeutics, Ltd. quarterly profit compared to last year may be significant for companies with a seasonal business. But the main indicator of the company's profitability is the annual change in profit.
The dynamics of the company's profit is displayed as a percentage. In the table of the Quarterly Profit service on this page, you can find the history of ImmunoCellular Therapeutics, Ltd. profit for previous reporting periods, for the last year or other interval. ImmunoCellular Therapeutics, Ltd. quarterly earnings history is available online for each year and quarter over the past ten years. The database of profit for the past year and other periods of ImmunoCellular Therapeutics, Ltd. is compiled from public sources.
